Stock of the Week <style type="text/css">.ReadMsgBody { width: 100%; background-color: #E6F0FA; } .ExternalClass { width: 100%; background-color: #E6F0FA; } .ExternalClass, .ExternalClass p, .ExternalClass span, .ExternalClass font, .ExternalClass td, .ExternalClass div { line-height: 100%; } body { margin: 0; padding: 0; -webkit-text-size-adjust: none; -ms-text-size-adjust: none; } div, p, a, li, td { -webkit-text-size-adjust: none; -ms-text-size-adjust: none; } table td { -webkit-text-size-adjust: none; border-spacing: 0; border-collapse: collapse; border:0 none; mso-table-lspace: 0pt; mso-table-rspace: 0pt; } a[href^="https"] { text-decoration: none; } /* Constrain email width for small screens */ @media screen and (max-width: 650px) { table[class="container"] { width: 96%!important; -moz-box-sizing:border-box; -webkit-box-sizing:border-box; box-sizing:border-box; margin:0 auto; } } /* Styles for forcing columns to rows */ @media only screen and (max-width : 650px) { /* force container columns to (horizontal) blocks */ td[class="force-col"] { display: block; text-align: left; width: auto!important; } img[class="fullwidth-img"] { width: 100%!important; } /* Make telephone numbers pretty */ a[href~="tel"] { color:#d35400!important; } /* OFFERS TABLE LAYOUT */ td[class="offers-table-header-force-col"] { border-bottom:none!important; display: block; text-align: left; width: auto!important; } td[class="offers-table-force-col"] { display: block; text-align: left; width: auto!important; padding:0 10px 10px!important; } /* TEXT WITH IMAGE LAYOUT */ td[class="textimg-img-col"] { border-bottom:none!important; display: block; text-align: left; width: auto!important; padding:10px 10px 0!important } td[class="textimg-text"] { border-bottom:none!important; display: block; text-align: left; width: auto!important; } /* 3 COL LAYOUTS */ table[class="col-3"] { border-bottom:1px solid #535353; margin-bottom:12px; } table[id="last-col-3"] { border-bottom:none; margin-bottom:0; } img[class="col-3-img"] { float: right; margin-left: 6px; max-width: 130px; } }</style>

One Big Pick. Once a Week.

NDTP DROPS MAJOR GOVERNMENT CONTRACT NEWS THIS MORNING! COULD WE SEE A MOVE PAST $2 TODAY?

logo
NDT PHARMACEUTICALS INC.

US PINK SYMBOL: NDTP
Website | SEC Filings | Latest News

Today's Alert on NDT Pharmaceuticals, Inc. (OTC: NDTP) is already off to a solid start here in just the first hour of trading!

AND WE'RE JUST GETTING STARTED...

So far we've seen an easy 14% GAIN on the day here at 1.58 while touching highs of 1.90 at the open!

This is a HUGE sign of the type of price movement we can anticipate when Today's Mega News starts to trickle onto Wall Street radars!! Especially with it's TINY FLOAT...

NDT Pharmaceuticals' Subsidiary, Good Salt(TM) Life, Secures Major Government Contract, Deploying Advanced Biosafety Ecosystem in Tennessee State Prisons

ATHENS, GA / ACCESS Newswire / November 24, 2025 / NDT Pharmaceuticals Inc. (OTC:NDTP), a company focused on advancing sustainable health and wellness solutions, today announced a significant contract win for its wholly-owned subsidiary, Good Salt™ Life, LLC. The Tennessee Department of Correction (TDOC) has purchased Good Salt Life's ByoCart Sprayer units, Clean Republic Disinfectant to modernize hygiene and infection-control protocols across its correctional facilities, representing another major institutional deployment for the company.

This contract includes $300,000 in initial equipment purchases and is expected to generate additional recurring annual revenue through ongoing disinfectant replenishment, establishing a multi-year revenue stream as TDOC adopts Good Salt Life's biosafety platform as part of its long-term facility hygiene strategy.

UNBELIEVABLE! News doesn't get any better than this!

Price action is now picking up for this quiet stock and that could translate into continued GAINS...

chart

Here’s what the chart is telling us:

📈 Price hovering above long-term trendlines
📈 Resistance thinning → small volume can break levels
📈 MACD curling underneath — potential bullish cross?
📈 RSI sitting in neutral territory = room to run
📈 Support forming under recent price action
📈 Tightening = pre-breakout coil

We’ve seen this pattern countless times:

When low-float OTC stocks coil quietly… the move is rarely quiet.

And with NDTP’s recent chart Breakout & TINY Float of just 16.9 MIL shares a/o 8/16/2025, ANY continuation of this momentum could create a MAJOR MOVE.

Not to mention, Investing.com has now given NDTP it's highest rating of "STRONG BUY"

THE BOTTOM LINE
Today's MEGA News may just be the catalyst we needed!

REMEMBER: For an OTC Penny Stock in the Pharma/Wellness Sector, NDTP absolutely checks every box...

🔥 A GROWING operating subsidiary (Good Salt Life™)
🔥 Targeting a massive global market
🔥 Distribution in big-box retail ecosystems
🔥 HOCl tech = trending in both medical and consumer health
🔥 Low float
🔥 OTC = explosive potential on volume surges

AND WALL STREET IS BARELY WATCHING NDTP… YET!

No analysts.
No glowing research notes.
No mainstream fund ownership.
No CNBC segments.

Barely a soul is watching this. But this is EXACTLY how major low-float runs start.

REMEMBER WHERE YOU HEARD OF NDTP FIRST!

If you haven't yet, make sure you put it on your screen RIGHT NOW and Follow on Twitter for Updates + Play-by-Play!

Good Trading,

Editor
StockoftheWeek.net

Still need an Online Broker to place trades?

Do NOT use RobinHood! Our Team HIGHLY recommends ETRADE .

Website | Unsubscribe | View in Browser

We encourage all to read the SEC's INVESTOR ALERT before reading this Newsletter.

COMPENSATION: Stockoftheweek.net has been compensated fifty-five thousand dollars cash via bank wire by a third party, Shore Thing Media, LLC for this NDT Pharmaceuticals, Inc. marketing services contract. Stockoftheweek.net does not own any shares of NDTP. Stockoftheweek.net does not investigate the background of any third party. The third party may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

Disclaimer2